ARROWHEAD PHARMACEUTICALS, INC. — Net Income by Fiscal Year
23 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2d92481f-2552-416a-bb27-0ec95564daae/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.6M | 2024-10-01 – 2025-09-30 | evidence 0000879407-25-000029 |
| FY 2024 | $-599.5M | 2023-10-01 – 2024-09-30 | evidence 0001628280-24-049277 |
| FY 2023 | $-205.3M | 2022-10-01 – 2023-09-30 | evidence 0001628280-23-040219 |
| FY 2022 | $-176.1M | 2021-10-01 – 2022-09-30 | evidence 0001628280-22-030869 |
| FY 2021 | $-140.8M | 2020-10-01 – 2021-09-30 | evidence 0001564590-21-057888 |
| FY 2020 | $-84.6M | 2019-10-01 – 2020-09-30 | evidence 0001564590-21-057888 |
| FY 2019 | $68.0M | 2018-10-01 – 2019-09-30 | evidence 0001564590-21-057888 |
| FY 2018 | $-54.5M | 2017-10-01 – 2018-09-30 | evidence 0001564590-19-044376 |
| FY 2017 | $-34.4M | 2016-10-01 – 2017-09-30 | evidence 0001564590-19-044376 |
| FY 2016 | $-81.7M | 2015-10-01 – 2016-09-30 | evidence 0001564590-16-030217 |
| FY 2015 | $-91.9M | 2014-10-01 – 2015-09-30 | evidence 0001564590-15-011489 |
| FY 2014 | $-58.6M | 2013-10-01 – 2014-09-30 | evidence 0001564590-14-005961 |
| FY 2013 | $-190.5M | 2003-05-01 – 2014-03-31 | evidence 0001564590-14-001816 |
| FY 2012 | $-146.2M | 2003-05-01 – 2013-03-31 | evidence 0001193125-13-210998 |
| FY 2011 | $-121.5M | 2003-05-07 – 2012-03-31 | evidence 0001193125-12-218387 |
| FY 2010 | $-5.8M | 2009-10-01 – 2010-09-30 | evidence 0001193125-11-347334 |
| FY 2009 | $-19.3M | 2008-10-01 – 2009-09-30 | evidence 0001193125-11-214223 |
| FY 2008 | $-27.2M | 2007-10-01 – 2008-09-30 | evidence 0001193125-11-214223 |
| FY 2007 | $-30.7M | 2006-10-01 – 2007-09-30 | evidence 0001193125-11-214223 |
| FY 2006 | $-20.0M | 2005-10-01 – 2006-09-30 | evidence 0001193125-11-214223 |
| FY 2005 | $-6.7M | 2004-10-01 – 2005-09-30 | evidence 0001193125-11-214223 |
| FY 2004 | $-751.3k | 2003-10-01 – 2004-09-30 | evidence 0001193125-11-214223 |
| FY 2003 | $-95.2k | 2002-10-01 – 2003-09-30 | evidence 0001193125-11-214223 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARROWHEAD PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income